NFL Biosciences SA (ALNFL.PA)

EUR 1.38

(2.22%)

Operating Expenses Summary of NFL Biosciences SA

  • NFL Biosciences SA's latest annual operating expenses in 2023 was 4.37 Million EUR , up 553.91% from previous year.
  • NFL Biosciences SA's latest quarterly operating expenses in 2024 Q2 was 870.15 Thousand EUR , down -54.82% from previous quarter.
  • NFL Biosciences SA reported a annual operating expenses of 668.95 Thousand EUR in annual operating expenses 2022, up 13.62% from previous year.
  • NFL Biosciences SA reported a annual operating expenses of 588.76 Thousand EUR in annual operating expenses 2021, up 296.02% from previous year.
  • NFL Biosciences SA reported a quarterly operating expenses of 4.37 Million EUR for 2023 FY, up 553.91% from previous quarter.
  • NFL Biosciences SA reported a quarterly operating expenses of 1.92 Million EUR for 2023 Q4, down -21.34% from previous quarter.

Annual Operating Expenses Chart of NFL Biosciences SA (2023 - 2019)

Historical Annual Operating Expenses of NFL Biosciences SA (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 4.37 Million EUR 553.91%
2022 668.95 Thousand EUR 13.62%
2021 588.76 Thousand EUR 296.02%
2020 148.67 Thousand EUR 59.14%
2019 93.42 Thousand EUR 0.0%

Peer Operating Expenses Comparison of NFL Biosciences SA

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR -4.725%
ABIVAX Société Anonyme 127.37 Million EUR 96.566%
Adocia SA 15.62 Million EUR 72.011%
Aelis Farma SA 18.81 Million EUR 76.756%
Biophytis S.A. 14.33 Million EUR 69.481%
Advicenne S.A. 8.21 Million EUR 46.752%
genOway Société anonyme 16.73 Million EUR 73.866%
IntegraGen SA 5.35 Million EUR 18.275%
Medesis Pharma S.A. 1.56 Million EUR -179.588%
Neovacs S.A. 10.34 Million EUR 57.709%
Plant Advanced Technologies SA 2.76 Million EUR -58.213%
Quantum Genomics Société Anonyme 1.71 Million EUR -154.624%
Sensorion SA 27.05 Million EUR 83.831%
Theranexus Société Anonyme 3 Million EUR -45.57%
TME Pharma N.V. 5.49 Million EUR 20.423%
Valbiotis SA 9.86 Million EUR 55.676%
TheraVet SA 1.64 Million EUR -166.029%
Valerio Therapeutics Société anonyme 20.32 Million EUR 78.473%
DBV Technologies S.A. 89.4 Million EUR 95.107%
Genfit S.A. 54.8 Million EUR 92.018%
GeNeuro SA 14.35 Million EUR 69.532%
Innate Pharma S.A. 64.57 Million EUR 93.225%
Inventiva S.A. 120.18 Million EUR 96.36%
MaaT Pharma SA 21.59 Million EUR 79.746%
MedinCell S.A. 32.92 Million EUR 86.713%
Nanobiotix S.A. 58.92 Million EUR 92.577%
OSE Immunotherapeutics SA 23.58 Million EUR 81.456%
Poxel S.A. 28.76 Million EUR 84.793%
GenSight Biologics S.A. 32.66 Million EUR 86.606%
Transgene SA 31.23 Million EUR 85.994%
Valneva SE 134.92 Million EUR 96.758%